The Frequency and Clinical Relevance of Multidrug Resistance Protein Expression in Patients with Lymphoma
TURKISH JOURNAL OF HEMATOLOGY, vol.29, no.2, pp.120-125, 2012 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 29 Issue: 2
- Publication Date: 2012
- Doi Number: 10.5505/tjh.2012.60362
- Journal Name: TURKISH JOURNAL OF HEMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.120-125
- Keywords: Multidrug resistance, non-Hodgkin's lymphoma, Hodgkin's lymphoma, Survival, P-GLYCOPROTEIN EXPRESSION, GLUTATHIONE-S-TRANSFERASE, POLYMERASE-CHAIN-REACTION, ACUTE MYELOID-LEUKEMIA, DRUG-RESISTANCE, IMMUNOHISTOCHEMICAL EXPRESSION, REFRACTORY LYMPHOMA, POOR RESPONSE, CELL LYMPHOMA, GENE
- Eskisehir Osmangazi University Affiliated: Yes
Abstract
Objective: Multidrug resistance is a cause of treatment failure in patients with malignant lymphoma; however, the frequency and clinical relevance of multidrug resistance protein expression are unclear. The present study aimed to investigate expression of the most common multidrug resistance proteins in a group of lymphoma patients.